Argiolas A, Melis M R, Fadda F, Serra G, Gessa G L
J Neurochem. 1982 Jan;38(1):75-9. doi: 10.1111/j.1471-4159.1982.tb10855.x.
The effect of different psychotropic drugs on the rate of DOPA accumulation after administration of a decarboxylase inhibitor (NSD 1015) was compared in the substantia nigra (SN) and caudate nucleus (CN) by a new radioenzymatic method. Inhibition of monoamine oxidase with pargyline or stimulation of dopamine (DA) receptors with apomorphine, N-n-propylnorapomorphine or D-amphetamine reduced DOPA formation in the CN and SN to the same extent. Vice versa, both inhibition of DA receptors with haloperidol or (-)sulpiride and depletion of DA concentration with reserpine enhanced DOPA formation to a greater extent in the CN than in the SN. Apomorphine antagonized not only the effect of haloperidol and (-)sulpiride, but also, and even more effectively, that of reserpine. The results indicate that DA synthesis in the SN is controlled by both end-product inhibition and DA receptor-mediated mechanisms.
采用一种新的放射酶法,比较了不同精神药物对给予脱羧酶抑制剂(NSD 1015)后黑质(SN)和尾状核(CN)中多巴(DOPA)积累速率的影响。用优降宁抑制单胺氧化酶,或用阿扑吗啡、N - 正丙基去甲阿扑吗啡或D - 苯丙胺刺激多巴胺(DA)受体,均可使CN和SN中的DOPA生成减少至相同程度。反之,用氟哌啶醇或(-)舒必利抑制DA受体以及用利血平降低DA浓度,在CN中比在SN中更能增强DOPA的生成。阿扑吗啡不仅能拮抗氟哌啶醇和(-)舒必利的作用,而且更有效地拮抗利血平的作用。结果表明,SN中的DA合成受终产物抑制和DA受体介导机制的共同控制。